a Department of Psychology , University of Tulsa , Tulsa , OK.
b Department of Psychiatry , University of Iowa , Iowa City , IA.
J Clin Exp Neuropsychol. 2019 May;41(4):331-340. doi: 10.1080/13803395.2018.1562048. Epub 2019 Jan 14.
As many as 70% of people with multiple sclerosis (MS) have clinically significant cognitive impairment, and most of these individuals exhibit executive dysfunction. Most research concerning executive dysfunction in MS has focused upon nonverbal measures. The Verbal Concept Attainment Test (VCAT) has demonstrated construct validity as an executive function measure in people infected with HIV and in people with focal brain lesions, but its validity among people with MS is unknown. The current study evaluated the VCAT's criterion, diagnostic, and ecological validity in people with MS.
A comprehensive neuropsychological battery was administered to 44 healthy individuals and 97 people with MS. Based on existing norms, they were classified as impaired or unimpaired, resulting in 65 people with MS categorized as unimpaired and 32 as impaired. They were administered a battery assessing neuropsychological impairment and disability status.
The VCAT correlated with most measures of neuropsychological function, but its largest correlations occurred with measures of executive function, working memory, and verbal memory. Regarding classification accuracy, the VCAT achieved satisfactory sensitivity and specificity in identifying neuropsychological impairment in people with MS. The VCAT achieved moderate correlations with measures of disability status.
The data provide evidence for an optimal VCAT cutoff score for establishing neuropsychological impairment in people with MS, and they demonstrate that the VCAT possesses acceptable criterion, diagnostic, and ecological validity. As such, these data support the inclusion of the VCAT in research and clinical practice involving people with MS.
多达 70%的多发性硬化症(MS)患者存在明显的认知障碍,其中大多数患者表现出执行功能障碍。大多数关于 MS 执行功能障碍的研究都集中在非言语测量上。言语概念获得测试(VCAT)已在感染 HIV 的人群和局灶性脑损伤人群中证明了其作为执行功能测量的结构有效性,但在 MS 人群中的有效性尚不清楚。本研究评估了 VCAT 在 MS 患者中的效标、诊断和生态有效性。
对 44 名健康个体和 97 名 MS 患者进行了全面的神经心理学测试。根据现有标准,他们被分为受损或未受损,其中 65 名 MS 患者被归类为未受损,32 名患者被归类为受损。他们接受了一套评估神经心理学损伤和残疾状况的测试。
VCAT 与大多数神经心理学功能测试相关,但与执行功能、工作记忆和言语记忆的测试相关性最大。关于分类准确性,VCAT 在识别 MS 患者的神经心理损伤方面具有令人满意的敏感性和特异性。VCAT 与残疾状况的衡量标准呈中度相关。
数据为在 MS 患者中建立神经心理损伤的最佳 VCAT 截断分数提供了证据,并且表明 VCAT 具有可接受的效标、诊断和生态有效性。因此,这些数据支持在涉及 MS 患者的研究和临床实践中纳入 VCAT。